Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ren, Yan  [Clear All Filters]
2023
Liu J, Li X, Wang H, Ren Y, Li Y, Guo F. Bavachinin selectively modulates PPAR γ and maintains bone homeostasis in Type 2 Diabetes. Phytother Res. 2023.
Ren Y, Cui Y, Tan Y, Xu Z, Wang H. Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro. Vox Sang. 2023.
Ren Y, Cui Y, Feng J, Tan Y, Ren F, Zhang Y, Wang H. Synergistic effect and molecular mechanism of PVA and UM171 in ex vivo expansion of primitive hematopoietic stem cells. J Cell Biochem. 2023.
2022
Huang L, Shuai X, Zhang T, Kuang P, Zhang D, Chen T, Tian H, Xiang B, Ren Y. The combination of early identification, chemotherapy, and autologous stem cell transplantation obtained favorable outcomes in unilateral primary adrenal lymphoma: A case report. Endocrine. 2022.
2021
Liu H, Deng S, Han L, Ren Y, Gu J, He L, Liu T, Yuan Z-X. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids Surf B Biointerfaces. 2021;209(Pt 1):112163.
2019
Kalff A, Khong T, Mithraprabhu S, Bergin K, Reynolds J, Bowen KM, Thakurta A, Guzman R, Wang M, Couto S, et al. Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study). Leuk Lymphoma. 2019:1-9.
2015
Liu R, Jia W, Zou H, Wang X, Ren Y, Zhao J, Wang L, Li M, Qi Y, Shen Y, et al. Expression of CD44 and CD29 by PEComa cells suggests their possible origin of mesenchymal stem cells. Int J Clin Exp Pathol. 2015;8(10):13023-33.
Shi H, Fu Q, Li G, Ren Y, Hu S, Ni W, Guo F, Shi M, Meng L, Zhang H, et al. Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells. Cell Reprogram. 2015.